Glenmark Pharma shares rise over 2% as unit files US application for experimental solid-tumour drug
Shares of Glenmark Pharmaceuticals Ltd rallied over 2.5 percent in Wednesday’s trading session, November 18, after the pharmaceutical major’s innovation arm, Ichnos Glenmark Innovation (IGI), filed an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) for its…